Pyruvate Kinase Activation in the Management of Thalassemia and Sickle Cell Disease
- 9 June 2026
- journal article
- review article
- Published by Taylor & Francis in Hemoglobin
- Vol. 50 (4) , 1-13
Abstract
Inherited disorders of hemoglobin, including thalassemia and sickle cell disease (SCD), are among the most common monogenic diseases worldwide. They are no longer confined to the region extending f...Keywords
This publication has 103 references indexed in Scilit:
- Pyruvate Kinase Function Correlates With Red Blood Cell Properties and Clinical Manifestations in Sickle Cell DiseaseAmerican Journal of Hematology, 2025
- Effects of 2,3‐DPG knockout on SCD phenotype in Townes SCD model miceAmerican Journal of Hematology, 2023
- Epidemiology of clinically significant forms of alpha‐ and beta‐thalassemia: A global map of evidence and gapsAmerican Journal of Hematology, 2023
- Overall and complication‐free survival in a large cohort of patients with β‐thalassemia major followed over 50 yearsAmerican Journal of Hematology, 2023
- Burden of disease, treatment utilization, and the impact on education and employment in patients with sickle cell disease: A comparative analysis of high‐ and low‐ to middle‐income countries for the international Sickle Cell World Assessment SurveyAmerican Journal of Hematology, 2022
- Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in sickle cell disease: A phase 2, open‐label studyAmerican Journal of Hematology, 2022
- Risk of mortality from anemia and iron overload in nontransfusion‐dependent β‐thalassemiaAmerican Journal of Hematology, 2021
- Real‐Life experience with hydroxyurea in patients with sickle cell disease: Results from the prospective ESCORT‐HU cohort studyAmerican Journal of Hematology, 2021
- Impact of sickle cell disease on patientsʼ daily lives, symptoms reported, and disease management strategies: Results from the international Sickle Cell World Assessment Survey (SWAY)American Journal of Hematology, 2020
- Quality of life in patients with β‐thalassemia: A prospective study of transfusion‐dependent and non‐transfusion‐dependent patients in Greece, Italy, Lebanon, and ThailandAmerican Journal of Hematology, 2019